Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 182

1.

Surveillance After Treatment of Non-Small-Cell Lung Cancer: A Call for Multidisciplinary Standardization.

Mitchell KG, Nelson DB, Corsini EM, Correa AM, Erasmus JJ, Hofstetter WL, Mehran RJ, Roth JA, Swisher SG, Sepesi B, Walsh GL, Vaporciyan AA, Rice DC, Nguyen QN, Antonoff MB.

Innovations (Phila). 2019 Dec 26:1556984519886281. doi: 10.1177/1556984519886281. [Epub ahead of print]

PMID:
31875755
2.

Preoperative Heparin for Lung Cancer Resection Increases Risk of Reoperation for Bleeding.

Van Haren RM, Rajaram R, Correa AM, Mehran RJ, Antonoff MB, Hofstetter WL, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC, Roth JA.

Semin Thorac Cardiovasc Surg. 2019 Dec 17. pii: S1043-0679(19)30384-3. doi: 10.1053/j.semtcvs.2019.12.001. [Epub ahead of print]

PMID:
31857153
3.

Multidisciplinary treatment of thymic neuroendocrine tumors: surgery remains a key component.

Corsini EM, Mitchell KG, Sceusi EL, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Swisher SG, Roth JA, Vaporciyan AA, Hofstetter WL, Antonoff MB.

J Thorac Dis. 2019 Aug;11(8):3391-3398. doi: 10.21037/jtd.2019.08.20.

4.

Time Trends of Perioperative Outcomes in Early Stage Non-Small Cell Lung Cancer Resection Patients.

Shewale JB, Correa AM, Brown EL, Leon-Novelo LG, Nyitray AG, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Walsh GL, Roth J, Vaporciyan AA, Swisher SG, Sepesi B.

Ann Thorac Surg. 2019 Sep 17. pii: S0003-4975(19)31400-6. doi: 10.1016/j.athoracsur.2019.08.018. [Epub ahead of print]

PMID:
31539514
5.

Morbidity following salvage esophagectomy for squamous cell carcinoma: the MD Anderson experience.

Mitchell KG, Nelson DB, Corsini EM, Vaporciyan AA, Antonoff MB, Mehran RJ, Rice DC, Roth JA, Sepesi B, Walsh GL, Bhutani MS, Maru DM, Wu CC, Nguyen QN, Ajani JA, Swisher SG, Hofstetter WL.

Dis Esophagus. 2019 Jul 17. pii: doz067. doi: 10.1093/dote/doz067. [Epub ahead of print]

PMID:
31313820
6.

Colorectal cancer mutations are associated with survival and recurrence after pulmonary metastasectomy.

Corsini EM, Mitchell KG, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Swisher SG, Roth JA, Hofstetter WL, Vaporciyan AA, Morris VK, Antonoff MB.

J Surg Oncol. 2019 Sep;120(4):729-735. doi: 10.1002/jso.25630. Epub 2019 Jul 9.

PMID:
31290159
7.

Tumor characteristics associated with engraftment of patient-derived non-small cell lung cancer xenografts in immunocompromised mice.

Chen Y, Zhang R, Wang L, Correa AM, Pataer A, Xu Y, Zhang X, Ren C, Wu S, Meng QH, Fujimoto J, Jensen VB, Antonoff MB, Hofstetter WL, Mehran RJ, Pisimisis G, Rice DC, Sepesi B, Vaporciyan AA, Walsh GL, Swisher SG, Roth JA, Heymach JV, Fang B.

Cancer. 2019 Nov 1;125(21):3738-3748. doi: 10.1002/cncr.32366. Epub 2019 Jul 9.

PMID:
31287557
8.

Glutathione reductase (GSR) gene deletion and chromosome 8 aneuploidy in primary lung cancers detected by fluorescence in situ hybridization.

Baity M, Wang L, Correa AM, Zhang X, Zhang R, Pataer A, Wu S, Meng QH, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Zhao M, Gu J, Fang B.

Am J Cancer Res. 2019 Jun 1;9(6):1201-1211. eCollection 2019.

9.

A case report of a midesophageal diverticulum mimicking a fibrovascular esophageal polyp.

Mitchell KG, Corsini EM, Van Haren RM, Walsh GL, Sepesi B.

Int J Surg Case Rep. 2019;59:205-207. doi: 10.1016/j.ijscr.2019.05.047. Epub 2019 May 31.

10.

Defining the role of adjuvant radiotherapy for malignant pleural mesothelioma: a propensity-matched landmark analysis of the National Cancer Database.

Nelson DB, Rice DC, Mitchell KG, Tsao AS, Vaporciyan AA, Antonoff MB, Hofstetter WL, Walsh GL, Swisher SG, Roth JA, Gomez DR, Mehran RJ, Sepesi B.

J Thorac Dis. 2019 Apr;11(4):1269-1278. doi: 10.21037/jtd.2019.04.27.

11.

Mediastinal Nodal Involvement After Neoadjuvant Chemoradiation for Siewert II/III Adenocarcinoma.

Mitchell KG, Ikoma N, Nelson DB, Maru DM, Erasmus JJ, Weston BR, Vaporciyan AA, Antonoff MB, Mehran RJ, Rice DC, Roth JA, Swisher SG, Sepesi B, Walsh GL, Correa AM, Das P, Blum MA, Badgwell BD, Hofstetter WL.

Ann Thorac Surg. 2019 Sep;108(3):845-851. doi: 10.1016/j.athoracsur.2019.04.024. Epub 2019 May 15.

PMID:
31102632
12.

Robotic-Assisted Lobectomy for Non-Small Cell Lung Cancer: A Comprehensive Institutional Experience.

Nelson DB, Mehran RJ, Mitchell KG, Rajaram R, Correa AM, Bassett RL Jr, Antonoff MB, Hofstetter WL, Roth JA, Sepesi B, Swisher SG, Walsh GL, Vaporciyan AA, Rice DC.

Ann Thorac Surg. 2019 Aug;108(2):370-376. doi: 10.1016/j.athoracsur.2019.03.051. Epub 2019 Apr 18.

PMID:
31004583
13.

Should endoscopic mucosal resection be attempted for cT2N0 esophageal cancer?

Nelson DB, Mitchell KG, Weston BR, Betancourt S, Maru D, Rice DC, Mehran RJ, Sepesi B, Antonoff MB, Walsh GL, Swisher SG, Roth JA, Vaporciyan AA, Blum M, Hofstetter WL.

Dis Esophagus. 2019 Dec 13;32(10):1-6. doi: 10.1093/dote/doz016.

PMID:
30888418
14.

Occult stage IIIA-N2 patients have excellent overall survival with initial surgery.

Kim MP, Correa AM, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Erasmus JJ, Swisher SG.

J Thorac Dis. 2018 Dec;10(12):6670-6676. doi: 10.21037/jtd.2018.10.94.

15.

Surgical margins and risk of local recurrence after wedge resection of colorectal pulmonary metastases.

Nelson DB, Tayob N, Mitchell KG, Correa AM, Hofstetter WL, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Antonoff MB, Roth JA, Rice DC, Vauthey JN, Mehran RJ.

J Thorac Cardiovasc Surg. 2019 Apr;157(4):1648-1655. doi: 10.1016/j.jtcvs.2018.10.156. Epub 2018 Nov 26.

PMID:
30635188
16.

Ground Glass Lesions on Chest Imaging: Evaluation of Reported Incidence in Cancer Patients Using Natural Language Processing.

Van Haren RM, Correa AM, Sepesi B, Rice DC, Hofstetter WL, Mehran RJ, Vaporciyan AA, Walsh GL, Roth JA, Swisher SG, Antonoff MB.

Ann Thorac Surg. 2019 Mar;107(3):936-940. doi: 10.1016/j.athoracsur.2018.09.016. Epub 2018 Oct 26.

PMID:
30612991
17.

Perioperative Outcomes for Stage I Non-Small Cell Lung Cancer: Differences Between Men and Women.

Nelson DB, Lapid DJ, Mitchell KG, Correa AM, Hofstetter WL, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA, Antonoff MB.

Ann Thorac Surg. 2018 Nov;106(5):1499-1503. doi: 10.1016/j.athoracsur.2018.06.070. Epub 2018 Aug 15.

PMID:
30118712
18.

Predictors of survival after resection of primary sarcomas of the chest wall-A large, single-institution series.

Shewale JB, Mitchell KG, Nelson DB, Conley AP, Rice DC, Antonoff MB, Hofstetter WL, Walsh GL, Swisher SG, Roth JA, Mehran RJ, Vaporciyan AA, Weissferdt A, Sepesi B.

J Surg Oncol. 2018 Sep;118(3):518-524. doi: 10.1002/jso.25162. Epub 2018 Aug 15.

PMID:
30109699
19.

Genetic variants in cytokine signaling pathways and clinical outcomes in early-stage lung cancer patients.

Sepesi B, Ye Y, Mitchell KG, Zhang L, Gu J, Ji L, Antonoff MB, Hofstetter WL, Rice DC, Mehran RJ, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA, Wu X.

J Thorac Cardiovasc Surg. 2018 Jun;155(6):2635-2645.e15. doi: 10.1016/j.jtcvs.2018.02.015. Epub 2018 Feb 15.

PMID:
29548588
20.

Clinicoradiographic Predictors of Aggressive Biology in Lung Cancer With Ground Glass Components.

Nelson DB, Godoy MCB, Benveniste MF, Shewale JB, Spicer JD, Mitchell KG, Hofstetter WL, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA, Antonoff MB.

Ann Thorac Surg. 2018 Jul;106(1):235-241. doi: 10.1016/j.athoracsur.2018.02.020. Epub 2018 Mar 11.

PMID:
29534957
21.

Enhanced Recovery Decreases Pulmonary and Cardiac Complications After Thoracotomy for Lung Cancer.

Van Haren RM, Mehran RJ, Mena GE, Correa AM, Antonoff MB, Baker CM, Woodard TC, Hofstetter WL, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC.

Ann Thorac Surg. 2018 Jul;106(1):272-279. doi: 10.1016/j.athoracsur.2018.01.088. Epub 2018 Mar 9.

PMID:
29530770
22.

Natural History of Ground-Glass Lesions Among Patients With Previous Lung Cancer.

Shewale JB, Nelson DB, Rice DC, Sepesi B, Hofstetter WL, Mehran RJ, Vaporciyan AA, Walsh GL, Swisher SG, Roth JA, Antonoff MB.

Ann Thorac Surg. 2018 Jun;105(6):1671-1677. doi: 10.1016/j.athoracsur.2018.01.031. Epub 2018 Feb 9.

PMID:
29432718
23.

Predictors of trimodality therapy and trends in therapy for malignant pleural mesothelioma.

Nelson DB, Rice DC, Niu J, Atay SM, Vaporciyan AA, Antonoff MB, Hofstetter WL, Walsh GL, Swisher SG, Roth JA, Tsao AS, Gomez DR, Giordano SH, Mehran RJ, Sepesi B.

Eur J Cardiothorac Surg. 2018 May 1;53(5):960-966. doi: 10.1093/ejcts/ezx427.

PMID:
29211849
24.

Variants with a low allele frequency detected in genomic DNA affect the accuracy of mutation detection in cell-free DNA by next-generation sequencing.

Wang JF, Pu X, Zhang X, Chen K, Xi Y, Wang J, Mao X, Zhang J, Heymach JV, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Meng QH, Shaw KR, Eterovic AK, Fang B.

Cancer. 2018 Mar 1;124(5):1061-1069. doi: 10.1002/cncr.31152. Epub 2017 Nov 27.

25.

Pathological complete response in patients with esophageal cancer after the trimodality approach: The association with baseline variables and survival-The University of Texas MD Anderson Cancer Center experience.

Blum Murphy M, Xiao L, Patel VR, Maru DM, Correa AM, G Amlashi F, Liao Z, Komaki R, Lin SH, Skinner HD, Vaporciyan A, Walsh GL, Swisher SG, Sepesi B, Lee JH, Bhutani MS, Weston B, Hofstetter WL, Ajani JA.

Cancer. 2017 Nov 1;123(21):4106-4113. doi: 10.1002/cncr.30953. Epub 2017 Sep 8.

26.

Long-Term Survival Outcomes of Cancer-Directed Surgery for Malignant Pleural Mesothelioma: Propensity Score Matching Analysis.

Nelson DB, Rice DC, Niu J, Atay S, Vaporciyan AA, Antonoff M, Hofstetter WL, Walsh GL, Swisher SG, Roth JA, Tsao A, Gomez D, Giordano SH, Mehran R, Sepesi B.

J Clin Oncol. 2017 Oct 10;35(29):3354-3362. doi: 10.1200/JCO.2017.73.8401. Epub 2017 Aug 17.

PMID:
28817374
27.

Salvage pulmonary resection after stereotactic body radiotherapy: A feasible and safe option for local failure in selected patients.

Antonoff MB, Correa AM, Sepesi B, Nguyen QN, Walsh GL, Swisher SG, Vaporciyan AA, Mehran RJ, Hofstetter WL, Rice DC.

J Thorac Cardiovasc Surg. 2017 Aug;154(2):689-699. doi: 10.1016/j.jtcvs.2017.03.142. Epub 2017 Apr 14.

28.

Polytetrafluoroethylene or Acellular Dermal Matrix for Diaphragmatic Reconstruction?

Bassuner JK, Rice DC, Antonoff MB, Correa AM, Walsh GL, Vaporciyan AA, Garg N, Sepesi B, Swisher SG, Hofstetter WL, Roth JA, Mehran RJ.

Ann Thorac Surg. 2017 Jun;103(6):1710-1714. doi: 10.1016/j.athoracsur.2017.01.006. Epub 2017 Mar 31.

PMID:
28366460
29.

A Brief History of Thoracic Surgery at the University of Texas MD Anderson Cancer Center.

Walsh GL, Mehran RJ.

Semin Thorac Cardiovasc Surg. 2016 Autumn;28(3):719-726. doi: 10.1053/j.semtcvs.2016.08.016. Epub 2016 Sep 28.

PMID:
28285679
30.

Intercostal Nerve Blocks With Liposomal Bupivacaine: Demonstration of Safety, and Potential Benefits.

Mehran RJ, Walsh GL, Zalpour A, Cata JP, Correa AM, Antonoff MB, Rice DC.

Semin Thorac Cardiovasc Surg. 2017 Winter;29(4):531-537. doi: 10.1053/j.semtcvs.2017.06.004. Epub 2017 Jun 6.

PMID:
29698654
31.

The Influence of Reconstructive Technique on Perioperative Pulmonary and Infectious Outcomes Following Chest Wall Resection.

Spicer JD, Shewale JB, Antonoff MB, Correa AM, Hofstetter WB, Rice DC, Vaporciyan AA, Mehran RJ, Walsh GL, Roth JA, Swisher SG, Sepesi B.

Ann Thorac Surg. 2016 Nov;102(5):1653-1659. doi: 10.1016/j.athoracsur.2016.05.072. Epub 2016 Aug 12.

PMID:
27526650
32.

Pancreatic cancer patients and thoracic surgeons: Could/should their clinic templates ever overlap?

Walsh GL.

J Thorac Cardiovasc Surg. 2016 Jul;152(1):83-4. doi: 10.1016/j.jtcvs.2016.03.048. Epub 2016 Mar 30. No abstract available.

33.

Results of Postdischarge Nursing Telephone Assessments: Persistent Symptoms Common Among Pulmonary Resection Patients.

Antonoff MB, Ragalie W, Correa AM, Spicer JD, Sepesi B, Roth JA, Walsh GL, Hofstetter WL, Swisher SG, Rice DC, Vaporciyan AA, Mehran RJ.

Ann Thorac Surg. 2016 Jul;102(1):276-81. doi: 10.1016/j.athoracsur.2016.01.062. Epub 2016 Apr 12.

PMID:
27083250
34.

Survival in Patients With Esophageal Adenocarcinoma Undergoing Trimodality Therapy Is Independent of Regional Lymph Node Location.

Sepesi B, Schmidt HE, Lada M, Correa AM, Walsh GL, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Ajani JA, Watson TJ, Swisher SG, Low DE, Hofstetter WL.

Ann Thorac Surg. 2016 Mar;101(3):1075-80; Discussion 1080-1. doi: 10.1016/j.athoracsur.2015.09.063. Epub 2015 Dec 8.

PMID:
26680311
35.

Clinical Prediction of Pathologic Complete Response in Superior Sulcus Non-Small Cell Lung Cancer.

Antonoff MB, Hofstetter WL, Correa AM, Bell JM, Sepesi B, Rice DC, Vaporciyan AA, Walsh GL, Mehran RJ, Swisher SG, Meyers BF.

Ann Thorac Surg. 2016 Jan;101(1):211-7. doi: 10.1016/j.athoracsur.2015.06.019. Epub 2015 Aug 14.

PMID:
26279367
36.

Microsurgical reconstruction of combined tracheal and total esophageal defects.

Ghali S, Chang EI, Rice DC, Walsh GL, Yu P.

J Thorac Cardiovasc Surg. 2015 Nov;150(5):1261-6. doi: 10.1016/j.jtcvs.2011.10.100. Epub 2015 May 7.

37.

Limitations of 18F-2-deoxy-D-glucose positron emission tomography in N1 detection in patients with pathologic stage II-N1 and implications for management.

Kim MP, Correa AM, Hofstetter W, Mehran R, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Erasmus JJ, Swisher SG.

Ann Thorac Surg. 2015 Feb;99(2):414-20. doi: 10.1016/j.athoracsur.2014.09.023. Epub 2014 Dec 11.

PMID:
25497068
38.

Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer.

Hao C, Wang L, Peng S, Cao M, Li H, Hu J, Huang X, Liu W, Zhang H, Wu S, Pataer A, Heymach JV, Eterovic AK, Zhang Q, Shaw KR, Chen K, Futreal A, Wang M, Hofstetter W, Mehran R, Rice D, Roth JA, Sepesi B, Swisher SG, Vaporciyan A, Walsh GL, Johnson FM, Fang B.

Cancer Lett. 2015 Feb 1;357(1):179-185. doi: 10.1016/j.canlet.2014.11.024. Epub 2014 Nov 18.

39.

Surgical therapy of ground-glass opacities.

Sepesi B, Walsh GL.

Semin Diagn Pathol. 2014 Jul;31(4):289-92. doi: 10.1053/j.semdp.2014.06.006. Epub 2014 Jun 12. Review.

PMID:
25239273
40.

Serious postoperative infections following resection of common solid tumors: outcomes, costs, and impact of hospital surgical volume.

Avritscher EB, Cooksley CD, Rolston KV, Swint JM, Delclos GL, Franzini L, Swisher SG, Walsh GL, Mansfield PF, Elting LS.

Support Care Cancer. 2014 Feb;22(2):527-35. doi: 10.1007/s00520-013-2006-1. Epub 2013 Oct 19.

PMID:
24141699
41.

The influence of histopathologic tumor viability on long-term survival and recurrence rates following neoadjuvant therapy for esophageal adenocarcinoma.

Francis AM, Sepesi B, Correa AM, Blum MA, Erasmus JJ, Lee JH, Maru DM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Welsh JW, Swisher SG, Hofstetter WL; University of Texas MD Anderson Esophageal Cancer Group.

Ann Surg. 2013 Sep;258(3):500-7. doi: 10.1097/SLA.0b013e3182a196f4.

PMID:
24022442
42.

Diaphragmatic hernia after esophagectomy in 440 patients with long-term follow-up.

Ganeshan DM, Correa AM, Bhosale P, Vaporciyan AA, Rice D, Mehran RJ, Walsh GL, Iyer R, Roth JA, Swisher SG, Hofstetter WL.

Ann Thorac Surg. 2013 Oct;96(4):1138-1145. doi: 10.1016/j.athoracsur.2013.04.076. Epub 2013 Jun 25.

PMID:
23810174
43.

Visceral pleural invasion is not predictive of survival in patients with lung cancer and smaller tumor size.

David E, Thall PF, Kalhor N, Hofstetter WL, Rice DC, Roth JA, Swisher SG, Walsh GL, Vaporciyan AA, Wei C, Mehran RJ.

Ann Thorac Surg. 2013 Jun;95(6):1872-7; discussion 1877. doi: 10.1016/j.athoracsur.2013.03.085. Epub 2013 May 2.

44.

Predictors of recurrent pulmonary metastases and survival after pulmonary metastasectomy for colorectal cancer.

Blackmon SH, Stephens EH, Correa AM, Hofstetter W, Kim MP, Mehran RJ, Rice DC, Roth JA, Swisher SG, Walsh GL, Vaporciyan AA.

Ann Thorac Surg. 2012 Dec;94(6):1802-9. doi: 10.1016/j.athoracsur.2012.07.014. Epub 2012 Oct 11.

PMID:
23063195
45.

Omental reinforcement of the thoracic esophagogastric anastomosis: an analysis of leak and reintervention rates in patients undergoing planned and salvage esophagectomy.

Sepesi B, Swisher SG, Walsh GL, Correa A, Mehran RJ, Rice D, Roth J, Vaporciyan A, Hofstetter WL.

J Thorac Cardiovasc Surg. 2012 Nov;144(5):1146-50. doi: 10.1016/j.jtcvs.2012.07.085. Epub 2012 Aug 28.

46.

Supercharged pedicled jejunal interposition for esophageal replacement: a 10-year experience.

Blackmon SH, Correa AM, Skoracki R, Chevray PM, Kim MP, Mehran RJ, Rice DC, Roth JA, Swisher SG, Vaporciyan AA, Yu P, Walsh GL, Hofstetter WL.

Ann Thorac Surg. 2012 Oct;94(4):1104-11; discussion 1111-3. doi: 10.1016/j.athoracsur.2012.05.123. Epub 2012 Aug 29.

PMID:
22939245
47.

Fibrosingmediastinitis and consequent superior vena cava syndrome - A case report.

Kant S, Walsh GL.

J Thorac Dis. 2012 Aug;4(4):428-30. doi: 10.3978/j.issn.2072-1439.2012.01.01.

48.

Ethics of transparency in research reports.

Selvan MS, Subbian S, Cantor SB, Rodriguez A, Smith ML, Walsh GL.

Indian J Med Ethics. 2011 Jan-Mar;8(1):31-6.

49.

Does the timing of esophagectomy after chemoradiation affect outcome?

Kim JY, Correa AM, Vaporciyan AA, Roth JA, Mehran RJ, Walsh GL, Rice DC, Ajani JA, Maru DM, Bhutani MS, Welsh J, Marom EM, Swisher SG, Hofstetter WL.

Ann Thorac Surg. 2012 Jan;93(1):207-12; discussion 212-3. doi: 10.1016/j.athoracsur.2011.05.021. Epub 2011 Oct 1.

50.

The Society of Thoracic Surgeons practice guideline on the prophylaxis and management of atrial fibrillation associated with general thoracic surgery: executive summary.

Fernando HC, Jaklitsch MT, Walsh GL, Tisdale JE, Bridges CD, Mitchell JD, Shrager JB.

Ann Thorac Surg. 2011 Sep;92(3):1144-52. doi: 10.1016/j.athoracsur.2011.06.104. Review. No abstract available.

PMID:
21871327

Supplemental Content

Loading ...
Support Center